PI3 - peptidase inhibitor 3 Gene
Also Known as SKALP; trappin-2
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 477241
PI3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001290099.2 | NP_001277028.1 | elafin precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
elafin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(57)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10201 | Sorafenib | 99.85% | Yes | |
| HY-18085 | Quercetin | 99.80% | Yes | |
| HY-15244 | Alpelisib | 99.95% | Yes | |
| HY-101562 | Inavolisib | 99.96% | Unkown | |
| HY-B0633A | Hyaluronic acid | Activator | / | Yes |
| HY-13026 | Idelalisib | 99.94% | Yes | |
| HY-15346 | Copanlisib | 99.35% | Unkown | |
| HY-B0633 | Hyaluronic acid sodium | Activator | 98.0% | Unkown |
| HY-N0717 | L-Valine | 99.89% | Unkown | |
| HY-17508 | Clarithromycin | Inhibitor | 99.90% | Yes |
| HY-10201A | Sorafenib tosylate | 99.98% | Yes | |
| HY-15346A | Copanlisib dihydrochloride | 99.55% | Yes | |
| HY-B0965 | Thioridazine hydrochloride | 99.96% | Unkown | |
| HY-13685 | Miltefosine | Inhibitor | 99.92% | Yes |
| HY-14151 | Prucalopride | 99.93% | Yes | |
| HY-B0648 | Medroxyprogesterone | Agonist | 98.82% | Unkown |
| HY-18085R | Quercetin (Standard) | 99.64% | Unkown | |
| HY-14153A | Tegaserod maleate | 99.90% | Unkown | |
| HY-12279 | Umbralisib | Inhibitor | 98.94% | Yes |
| HY-B1203 | Fludrocortisone | 98.99% | Yes | |
| HY-B0766 | Bicyclol | 99.91% | Unkown | |
| HY-N0146 | Quercetin dihydrate | ≥97.0% | Yes | |
| HY-14153 | Tegaserod | 99.71% | Unkown | |
| HY-N0717R | L-Valine (Standard) | 99.89% | Unkown | |
| HY-17635 | Leniolisib | Inhibitor | 99.38% | Yes |
| HY-B0965A | Thioridazine | 99.50% | Unkown | |
| HY-12694 | Prucalopride succinate | 99.94% | Yes | |
| HY-15856B | Flupentixol dihydrochloride | 99.73% | Yes | |
| HY-W008923 | Doxycycline monohydrate | 98.95% | Unkown | |
| HY-B0093 | Benazepril | 99.85% | Yes | |
| HY-B0319 | Tioconazole | Inhibitor | 99.90% | Unkown |
| HY-B1234 | Octinoxate | 99.84% | Unkown | |
| HY-90003 | Tianeptine | 99.84% | Unkown | |
| HY-N0565AR | Doxycycline (hydrochloride) (Standard) | 99.97% | Unkown | |
| HY-15244A | Alpelisib hydrochloride | 99.55% | Yes | |
| HY-17508R | Clarithromycin (Standard) | Inhibitor | 99.93% | Unkown |
| HY-N0565BR | Doxycycline hyclate (Standard) | 95.23% | Unkown | |
| HY-90003A | Tianeptine sodium salt | 99.90% | Unkown | |
| HY-B0093A | Benazepril hydrochloride | Inhibitor | 99.96% | Yes |
| HY-17635A | Leniolisib phosphate | Inhibitor | 98.88% | Yes |
| HY-N0565R | Doxycycline (Standard) | 97.16% | Unkown | |
| HY-B1550 | Benzoin | Inhibitor | 99.95% | Unkown |
| HY-15244R | Alpelisib (Standard) | 99.86% | Unkown | |
| HY-12279C | Umbralisib hydrochloride | Inhibitor | 99.04% | Yes |
| HY-N0565C | Doxycycline calcium | / | Unkown | |
| HY-12279A | Umbralisib tosylate | Inhibitor | / | Unkown |
| HY-12279B | Umbralisib sulfate | Inhibitor | / | Unkown |
| HY-15960 | PWT-33597 free base | / | Unkown | |
| HY-15960A | PWT-33597 | / | Unkown | |
| HY-15856A | Flupentixol | / | Unkown | |
| HY-15856BR | Flupentixol dihydrochloride (Standard) | / | Unkown | |
| HY-17457 | Levalbuterol hemitartrate | 98.71% | Yes | |
| HY-B0093AR | Benazepril hydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-B0965R | Thioridazine hydrochloride (Standard) | / | Unkown | |
| HY-B1203R | Fludrocortisone (Standard) | / | Unkown | |
| HY-W008923R | Doxycycline monohydrate (Standard) | / | Unkown | |
| HY-90003AR | Tianeptine sodium salt (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(82)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-18085A | Quercetin hydrate | 98.45% | Phase 4 | |
| HY-102031 | Linperlisib | Inhibitor | 98.83% | Phase 4 |
| HY-122620 | Rafutrombopag (tautomerism) | 98.33% | Phase 4 | |
| HY-18085G | Quercetin (GMP) | / | Phase 4 | |
| HY-145589 | Rafutrombopag | 95.29% | Phase 4 | |
| HY-14152 | Prucalopride hydrochloride | Agonist | / | Phase 4 |
| HY-W753806 | Doxazosin hydrochloride | Inhibitor | / | Phase 4 |
| HY-70063 | Buparlisib | 99.90% | Phase 3 | |
| HY-50673 | Dactolisib | 99.94% | Phase 3 | |
| HY-10681 | Gedatolisib | Inhibitor | 99.89% | Phase 3 |
| HY-19962 | Paxalisib | Inhibitor | 99.51% | Phase 3 |
| HY-13898 | Taselisib | Inhibitor | 99.75% | Phase 3 |
| HY-D0803 | Thymoquinone | 99.80% | Phase 3 | |
| HY-N0104 | Curcumol | Inducer | 99.50% | Phase 3 |
| HY-15174 | Dactolisib Tosylate | 99.87% | Phase 3 | |
| HY-12037 | Rigosertib sodium | 99.57% | Phase 3 | |
| HY-109068 | Parsaclisib | Inhibitor | 99.75% | Phase 3 |
| HY-15180 | Buparlisib Hydrochloride | 99.51% | Phase 3 | |
| HY-109198 | Zandelisib | Inhibitor | 99.67% | Phase 3 |
| HY-172581 | Clifutinib | 99.59% | Phase 3 | |
| HY-109068A | Parsaclisib hydrochloride | Inhibitor | 99.33% | Phase 3 |
| HY-50094 | Pictilisib | 99.80% | Phase 2 | |
| HY-100716 | Eganelisib | Inhibitor | 99.68% | Phase 2 |
| HY-139609 | Camonsertib | Inhibitor | 99.99% | Phase 2 |
| HY-19719 | Miransertib | Inhibitor | 99.32% | Phase 2 |
| HY-N0484 | Liensinine | 99.97% | Phase 2 | |
| HY-13522 | Fimepinostat | 99.95% | Phase 2 | |
| HY-15245 | GSK2636771 | Inhibitor | 99.88% | Phase 2 |
| HY-15177 | PF-04691502 | 99.33% | Phase 2 | |
| HY-N9481 | Lipoteichoic acid | / | Phase 2 | |
| HY-12513 | Samotolisib | 98.85% | Phase 2 | |
| HY-13246 | Apitolisib | 99.29% | Phase 2 | |
| HY-12868 | Bimiralisib | Inhibitor | 98.62% | Phase 2 |
| HY-13334A | BGT226 | 99.85% | Phase 2 | |
| HY-12330 | AZD8186 | Inhibitor | 99.98% | Phase 2 |
| HY-P0118B | Disitertide diammonium | 99.00% | Phase 2 | |
| HY-16526 | Pilaralisib | Inhibitor | 99.14% | Phase 2 |
| HY-10111 | TG100-115 | Inhibitor | 99.41% | Phase 2 |
| HY-15900 | Voxtalisib | Inhibitor | 99.82% | Phase 2 |
| HY-20180 | Pictilisib dimethanesulfonate | 99.72% | Phase 2 | |
| HY-19535A | Nemiralisib | Inhibitor | 99.80% | Phase 2 |
| HY-13334 | BGT226 maleate | 99.92% | Phase 2 | |
| HY-12948 | AMG319 | Inhibitor | 99.09% | Phase 2 |
| HY-N6775 | Sonolisib | Inhibitor | ≥99.0% | Phase 2 |
| HY-19719A | Miransertib hydrochloride | Inhibitor | 99.74% | Phase 2 |
| HY-10202 | Tandutinib | 99.48% | Phase 2 | |
| HY-115870 | AZD8154 | Inhibitor | 99.88% | Phase 2 |
| HY-132601A | Cobomarsen sodium | 99.29% | Phase 2 | |
| HY-P0118 | Disitertide | 98.03% | Phase 2 | |
| HY-17645 | Tenalisib | Inhibitor | 98.83% | Phase 2 |
| HY-10202A | Tandutinib hydrochloride | 99.29% | Phase 2 | |
| HY-10220 | SF1126 | Inducer | / | Phase 2 |
| HY-16754 | Seletalisib | Inhibitor | 99.79% | Phase 2 |
| HY-132601 | Cobomarsen | Inhibitor | / | Phase 2 |
| HY-135827A | Roginolisib hemifumarate | Inhibitor | 99.80% | Phase 2 |
| HY-N5014 | Liensinine perchlorate | 99.67% | Phase 2 | |
| HY-P0118A | Disitertide TFA | / | Phase 2 | |
| HY-19535 | Nemiralisib hydrochloride | Inhibitor | / | Phase 2 |
| HY-109029 | Dezapelisib | Inhibitor | / | Phase 2 |
| HY-N13200 | Cranberry Extract | / | Phase 2 | |
| HY-10108 | LY294002 | 99.95% | Phase 1 | |
| HY-10297 | Omipalisib | 99.94% | Phase 1 | |
| HY-101625 | Recilisib | Activator | 99.94% | Phase 1 |
| HY-159852 | BBO-10203 | 99.12% | Phase 1 | |
| HY-N2037 | Higenamine | 99.31% | Phase 1 | |
| HY-50847 | ZSTK474 | 99.71% | Phase 1 | |
| HY-16585 | VS-5584 | Inhibitor | 98.71% | Phase 1 |
| HY-19896 | COTI-2 | 99.02% | Phase 1 | |
| HY-12036 | GSK1059615 | 99.76% | Phase 1 | |
| HY-100886 | BAY1082439 | 99.35% | Phase 1 | |
| HY-162472 | XRD-0394 | Inhibitor | 98.54% | Phase 1 |
| HY-15837 | SAR-260301 | Inhibitor | 99.95% | Phase 1 |
| HY-15466 | Izorlisib | Inhibitor | 99.01% | Phase 1 |
| HY-11080 | PKI-179 | Inhibitor | 98.0% | Phase 1 |
| HY-12644 | Acalisib | Inhibitor | 99.98% | Phase 1 |
| HY-12869 | AZD-8835 | Inhibitor | 98.38% | Phase 1 |
| HY-124036 | DS-7423 | Inhibitor | 99.83% | Phase 1 |
| HY-15280 | GSK2292767 | Inhibitor | 98.89% | Phase 1 |
| HY-100694 | GS-9901 | Inhibitor | 99.97% | Phase 1 |
| HY-11080A | PKI-179 hydrochloride | Inhibitor | 99.66% | Phase 1 |
| HY-101625A | Recilisib sodium | Activator | / | Phase 1 |
| HY-114214 | CKD-712 | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99463 | Batiraxcept | Inhibitor | 99.91% | Phase 3 |
| HY-P991524 | MM-111 | Inhibitor | / | Phase 2 |
| HY-P99304 | Lumretuzumab | Inhibitor | ≥99.0% | Phase 1 |
| HY-P991641 | IMC-EB10 | Inhibitor | 98% | Phase 1 |
| HY-P991984 | SIBP-03 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(919)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-19312 | 3-Methyladenine | Inhibitor | 99.91% | Unkown |
| HY-P0175 | 740 Y-P | 99.67% | Unkown | |
| HY-10197 | Wortmannin | Inhibitor | 99.86% | Unkown |
| HY-12016 | KU-55933 | Inhibitor | 99.92% | Unkown |
| HY-N0728 | α-Linolenic acid | Inhibitor | 99.92% | Unkown |
| HY-11006 | KU-57788 | Inhibitor | 99.95% | Unkown |
| HY-12481 | SAR405 | Inhibitor | 99.74% | Unkown |
| HY-13002 | Torin 2 | 99.69% | Unkown | |
| HY-N0776 | Isorhamnetin | Inhibitor | 99.94% | Unkown |
| HY-156681 | Tersolisib | Inhibitor | 99.77% | Unkown |
| HY-12795 | Vps34-IN-1 | 99.79% | Unkown | |
| HY-154848 | UCL-TRO-1938 | Activator | 99.98% | Unkown |
| HY-113402 | Gamma-glutamylcysteine | 98.53% | Unkown | |
| HY-10115 | PI-103 | 99.82% | Unkown | |
| HY-124719 | hSMG-1 inhibitor 11j | Inhibitor | 99.82% | Unkown |
| HY-100355 | C18-Ceramide (d18:1/18:0) | 99.95% | Unkown | |
| HY-D0254 | Gallein | 98.0% | Unkown | |
| HY-P1410B | D-GsMTx4 | Inhibitor | 99.44% | Unkown |
| HY-N0451 | Acacetin | Inducer | 99.71% | Unkown |
| HY-110171 | iMDK | Inhibitor | 99.35% | Unkown |
| HY-N0143 | Phlorizin | 99.93% | Unkown | |
| HY-153306 | Zovegalisib | Inhibitor | 98.80% | Unkown |
| HY-10108A | LY294002 hydrochloride | 99.97% | Unkown | |
| HY-N0270 | Ononin | 99.97% | Unkown | |
| HY-N0022 | Isoacteoside | 99.73% | Unkown | |
| HY-113308A | Taurolithocholic acid sodium salt | 99.81% | Unkown | |
| HY-144806 | PI3K/AKT-IN-1 | 99.64% | Unkown | |
| HY-N0457 | Chicoric acid | Inducer | 99.86% | Unkown |
| HY-N0787 | Cryptochlorogenic acid | 99.87% | Unkown | |
| HY-12030 | PIK-90 | Inhibitor | 99.70% | Unkown |
| HY-151527 | PI3K/Akt/CREB activator 1 | 98.64% | Unkown | |
| HY-106591A | 4-Vinylcyclohexene dioxide | 98.57% | Unkown | |
| HY-N1435 | Oroxin B | 99.39% | Unkown | |
| HY-N0361 | Dihydrocapsaicin | 99.93% | Unkown | |
| HY-15719 | NU 7026 | 99.97% | Unkown | |
| HY-N0031 | Plantamajoside | 99.80% | Unkown | |
| HY-12037A | Rigosertib | 99.01% | Unkown | |
| HY-13425 | Deguelin | 99.20% | Unkown | |
| HY-N2515 | Ginsenoside Rk1 | 99.90% | Unkown | |
| HY-N0284 | Esculetin | Inhibitor | 99.79% | Unkown |
| HY-103450 | G36 | Antagonist | 99.35% | Unkown |
| HY-13532 | AS-252424 | Inhibitor | 99.66% | Unkown |
| HY-N0330 | Momordin Ic | 99.78% | Unkown | |
| HY-113308 | Taurolithocholic acid | 99.7% | Unkown | |
| HY-10114 | TGX-221 | Inhibitor | 99.59% | Unkown |
| HY-W011927 | 4,4'-Sulfonyldiphenol | 99.81% | Unkown | |
| HY-12046 | PIK-93 | Inhibitor | 99.81% | Unkown |
| HY-P1410C | D-GsMTx4 TFA | Inhibitor | 99.89% | Unkown |
| HY-P1925A | GO-203 TFA | 98.39% | Unkown | |
| HY-N0076 | Bilobalide | Inhibitor | 99.92% | Unkown |
| HY-116035 | Nimbolide | 99.79% | Unkown | |
| HY-124760 | hSMG-1 inhibitor 11e | Inhibitor | 99.94% | Unkown |
| HY-131615 | TPC2-A1-P | Agonist | 99.79% | Unkown |
| HY-N0103 | Sophocarpine | 99.85% | Unkown | |
| HY-N0563 | Alizarin | 99.48% | Unkown | |
| HY-N0815 | Resibufogenin | 99.93% | Unkown | |
| HY-I1124 | L-Valine-d8 | 99.91% | Unkown | |
| HY-N0448 | 10-Gingerol | 99.48% | Unkown | |
| HY-N1381 | Periplocin | Inducer | 99.81% | Unkown |
| HY-N0837 | Veratramine | 99.88% | Unkown | |
| HY-15477 | YS-49 | 99.98% | Unkown | |
| HY-18676 | OSU-T315 | 99.88% | Unkown | |
| HY-12794 | Vps34-PIK-III | Inhibitor | 99.63% | Unkown |
| HY-N2026 | Propylparaben | 99.96% | Unkown | |
| HY-N2187 | Deoxyshikonin | 99.96% | Unkown | |
| HY-N1346 | Robinin | 99.96% | Unkown | |
| HY-N6739 | Beauvericin | 99.97% | Unkown | |
| HY-18939 | N6-Cyclohexyladenosine | 99.98% | Unkown | |
| HY-N0847 | Micheliolide | Inhibitor | 99.77% | Unkown |
| HY-W010201 | Citronellol | 98.40% | Unkown | |
| HY-128483 | Fusaric acid | 99.94% | Unkown | |
| HY-N0717S6 | L-Valine-13C5 | 99.6% | Unkown | |
| HY-N0876 | Arenobufagin | Inducer | 99.82% | Unkown |
| HY-12068 | PI3K-IN-1 | Inhibitor | 99.93% | Unkown |
| HY-130413 | Protectin D1 | 99.10% | Unkown | |
| HY-150795 | SY-LB-35 | 99.54% | Unkown | |
| HY-N0265 | Asperosaponin VI | Inhibitor | 99.62% | Unkown |
| HY-131015 | HaXS8 | 99.28% | Unkown | |
| HY-128574 | D927 | Activator | 99.46% | Unkown |
| HY-160093 | SQLE-IN-1 | 99.21% | Unkown | |
| HY-N0819 | Raddeanin A | 98.68% | Unkown | |
| HY-N2593 | Isorhapontigenin | 99.82% | Unkown | |
| HY-103100 | SB-699551 | 99.53% | Unkown | |
| HY-N0493 | Pectolinarigenin | 99.98% | Unkown | |
| HY-N1255 | Scoulerine | 99.99% | Unkown | |
| HY-N7204 | 4-Hydroxyderricin | 99.79% | Unkown | |
| HY-10109 | AS-605240 | 99.36% | Unkown | |
| HY-15290 | AIM-100 | Inhibitor | 99.95% | Unkown |
| HY-118119 | CAY10526 | 99.12% | Unkown | |
| HY-156406 | PITCOIN4 | Inhibitor | 99.97% | Unkown |
| HY-N0078 | Ginkgolic Acid (C13:0) | Inhibitor | 99.92% | Unkown |
| HY-162713 | MTX-531 | 99.87% | Unkown | |
| HY-10044 | WYE-132 | 99.90% | Unkown | |
| HY-100398 | PF-04979064 | Inhibitor | 99.93% | Unkown |
| HY-110171A | iMDK quarterhydrate | Inhibitor | 99.37% | Unkown |
| HY-125848 | Ginsenoside F2 | 99.92% | Unkown | |
| HY-12763 | GNE-317 | Inhibitor | 98.76% | Unkown |
| HY-143404 | PI3K-IN-30 | Inhibitor | 98.19% | Unkown |
| HY-N2037A | Higenamine hydrochloride | 99.34% | Unkown | |
| HY-N2484 | Methylnissolin | Inhibitor | 99.92% | Unkown |
| HY-N0721 | Neoandrographolide | 99.41% | Unkown | |
| HY-N5112B | β,β-Dimethylacrylshikonin | 99.30% | Unkown | |
| HY-122862 | RAS inhibitor Abd-7 | Inhibitor | 99.57% | Unkown |
| HY-N1535 | Ponicidin | 99.93% | Unkown | |
| HY-Y1322 | Triphenyl phosphate | 99.67% | Unkown | |
| HY-N0616 | Trifolirhizin | 98.37% | Unkown | |
| HY-P4322 | H-Ile-Lys-Val-Ala-Val-OH | Activator | 99.35% | Unkown |
| HY-117163 | FzM1.8 | Agonist | 98.93% | Unkown |
| HY-P10580 | Vasculotide | Activator | 99.84% | Unkown |
| HY-10683 | PKI-402 | Inhibitor | 99.17% | Unkown |
| HY-10115A | PI-103 Hydrochloride | 98.06% | Unkown | |
| HY-13431 | KU-0060648 | Inhibitor | 99.87% | Unkown |
| HY-N0657 | Pinoresinol Diglucoside | 99.84% | Unkown | |
| HY-N2112 | Glaucocalyxin A | 99.88% | Unkown | |
| HY-N2554 | Osthenol | 99.15% | Unkown | |
| HY-N6263 | EGCG Octaacetate | Inhibitor | 98.57% | Unkown |
| HY-N6950 | Hederacolchiside A1 | 98.28% | Unkown | |
| HY-113402A | Gamma-glutamylcysteine TFA | 96.68% | Unkown | |
| HY-139534 | ARI-1 | 99.16% | Unkown | |
| HY-160099 | 20-5,14-HEDE | 98.34% | Unkown | |
| HY-N0660 | Jujuboside B | 99.92% | Unkown | |
| HY-N0712 | Typhaneoside | 99.74% | Unkown | |
| HY-N0777 | Isorhamnetin-3-O-glucoside | 99.96% | Unkown | |
| HY-N0885 | Telocinobufagin | 99.93% | Unkown | |
| HY-N2447 | Amarogentin | 99.93% | Unkown | |
| HY-N2491 | Deoxyelephantopin | Inhibitor | 99.87% | Unkown |
| HY-10110 | IC-87114 | Inhibitor | 99.85% | Unkown |
| HY-128741 | D-Allose | 99.85% | Unkown | |
| HY-N0735 | Phellodendrine chloride | 99.68% | Unkown | |
| HY-N2110 | Phellopterin | 99.94% | Unkown | |
| HY-N0696 | Sipeimine | Inhibitor | 98.57% | Unkown |
| HY-106012 | PI4K-IN-1 | Inhibitor | 98.59% | Unkown |
| HY-146751 | PI3K/Akt/mTOR-IN-2 | 99.93% | Unkown | |
| HY-N0314 | Pectolinarin | 99.89% | Unkown | |
| HY-N0728S3 | α-Linolenic acid-13C18 | Inhibitor | 99.5% | Unkown |
| HY-N3312 | Matairesinol | Inhibitor | 98.78% | Unkown |
| HY-135827 | Roginolisib | Inhibitor | 99.66% | Unkown |
| HY-N0747 | Oxypeucedanin | 99.50% | Unkown | |
| HY-N5027 | Oxyberberine | 99.78% | Unkown | |
| HY-W011927S | 4,4'-Sulfonyldiphenol-d8 | 99.21% | Unkown | |
| HY-N0726 | Dracorhodin perchlorate | 99.02% | Unkown | |
| HY-N1431 | Tabersonine | 98.13% | Unkown | |
| HY-101146 | SF2523 | Inhibitor | 99.34% | Unkown |
| HY-N0910 | Notoginsenoside Ft1 | 99.49% | Unkown | |
| HY-111570 | PI3Kγ inhibitor AZ2 | Inhibitor | 99.25% | Unkown |
| HY-13440 | AMG 511 | Inhibitor | 99.76% | Unkown |
| HY-141807 | MS21 | Degrader | 99.64% | Unkown |
| HY-N0534 | Vitexin-2"-O-rhamnoside | 99.78% | Unkown | |
| HY-N3354 | Lupiwighteone | Inducer | 98.92% | Unkown |
| HY-P10580A | Vasculotide TFA | Activator | 99.88% | Unkown |
| HY-11002 | CP-466722 | Inhibitor | 99.74% | Unkown |
| HY-115620 | AQX-016A | 99.51% | Unkown | |
| HY-156371 | MIPS-21335 | Inhibitor | 99.61% | Unkown |
| HY-D0892 | NSP-DMAE-NHS | 99.48% | Unkown | |
| HY-N0392 | Polygalasaponin F | 99.85% | Unkown | |
| HY-N0695 | Schisantherin B | 99.75% | Unkown | |
| HY-N0717S | L-Valine-15N | 99.74% | Unkown | |
| HY-N2081 | Skimmianine | Inhibitor | 99.90% | Unkown |
| HY-N4205 | Tetrahydropiperine | Inhibitor | 99.41% | Unkown |
| HY-N5048 | Galloylpaeoniflorin | Inhibitor | 98.30% | Unkown |
| HY-N6983 | Licoricesaponin G2 | 99.87% | Unkown | |
| HY-10811 | GNE-493 | Inhibitor | 99.81% | Unkown |
| HY-B0633D | Hyaluronic acid sodium (MW 200-1560) | 99.41% | Unkown | |
| HY-111508 | PI3K/mTOR Inhibitor-2 | Inhibitor | 99.10% | Unkown |
| HY-15672 | FM19G11 | Inhibitor | 98.39% | Unkown |
| HY-14971 | (E)-Akt inhibitor-IV | Inhibitor | 98.63% | Unkown |
| HY-19763 | Ifupinostat | 99.30% | Unkown | |
| HY-40029 | (S)-1-Boc-3-aminopiperidine | 99.95% | Unkown | |
| HY-B1885 | Fenitrothion | 99.43% | Unkown | |
| HY-N3651 | Curzerenone | 98.55% | Unkown | |
| HY-N6002 | 3'-Hydroxypterostilbene | Inducer | 99.89% | Unkown |
| HY-17044A | Duvelisib (R enantiomer) | Inhibitor | 99.00% | Unkown |
| HY-12034 | WYE-354 | 98.03% | Unkown | |
| HY-173405 | VVD-699 | Inhibitor | 99.83% | Unkown |
| HY-112440 | HZX-02-059 | Inhibitor | 99.40% | Unkown |
| HY-131972 | PF-06843195 | Inhibitor | 98.12% | Unkown |
| HY-117548 | UNC1062 | 98.92% | Unkown | |
| HY-118020A | Loliolide | 99.92% | Unkown | |
| HY-128393 | Trilinolein | 98.0% | Unkown | |
| HY-B0633I | Hyaluronic acid sodium (MW 800kDa) | / | Unkown | |
| HY-N0479 | Licarin B | Activator | 99.93% | Unkown |
| HY-N0717S1 | L-Valine-13C5,15N | 99.64% | Unkown | |
| HY-N0728R | α-Linolenic acid (Standard) | Inhibitor | 99.32% | Unkown |
| HY-N3127 | Orobol | Inhibitor | 99.74% | Unkown |
| HY-N5072 | Desmethylglycitein | Inhibitor | 99.99% | Unkown |
| HY-N1103 | Vasicine | 98.80% | Unkown | |
| HY-101272 | GDC-0326 | Inhibitor | 99.92% | Unkown |
| HY-19798 | PI4KIIIbeta-IN-9 | Inhibitor | 99.18% | Unkown |
| HY-101667 | LTURM34 | Inhibitor | 99.35% | Unkown |
| HY-112443 | AZD3458 | Inhibitor | 99.71% | Unkown |
| HY-100603 | GSK-F1 | Inhibitor | 95.06% | Unkown |
| HY-106263B | Tyroserleutide hydrochloride | 99.92% | Unkown | |
| HY-108016 | Peruvoside | 99.32% | Unkown | |
| HY-149669 | PH14 | Inhibitor | 99.29% | Unkown |
| HY-156681A | (S)-Tersolisib | Control | 99.18% | Unkown |
| HY-16441 | Tegafur-gimeracil-oteracil potassium | 99.96% | Unkown | |
| HY-16596 | CNX-1351 | Inhibitor | 98.87% | Unkown |
| HY-17587 | 4-Methylbenzylidene camphor | 99.87% | Unkown | |
| HY-N0103A | Sophocarpine monohydrate | 99.91% | Unkown | |
| HY-N0430A | Coptisine Sulfate | 99.37% | Unkown | |
| HY-N0902 | Dihydrosanguinarine | Inhibitor | 99.98% | Unkown |
| HY-N2132 | Flavokawain B | 99.99% | Unkown | |
| HY-N2787 | 8-Prenylnaringenin | 99.63% | Unkown | |
| HY-100470 | NSC781406 | Inhibitor | 99.97% | Unkown |
| HY-107365 | PQR530 | Inhibitor | 99.98% | Unkown |
| HY-112897 | IITZ-01 | 98.18% | Unkown | |
| HY-18085S1 | Quercetin-d3 | 98.73% | Unkown | |
| HY-100385 | Brevianamide F | Inhibitor | 99.03% | Unkown |
| HY-11095 | NPS 2390 | 99.90% | Unkown | |
| HY-126066 | (-)-Syringaresinol | 99.93% | Unkown | |
| HY-13531 | AS-604850 | Inhibitor | 99.32% | Unkown |
| HY-149091 | KDM5B-IN-4 | Inhibitor | 99.68% | Unkown |
| HY-15294 | CZC24832 | Inhibitor | 99.07% | Unkown |
| HY-161615 | PROTAC ATR degrader-2 | 99.73% | Unkown | |
| HY-172741 | Dioctanoyl PI(3,5)P2 sodium | 98.7% | Unkown | |
| HY-G0007 | Omeprazole sulfone | Control | 99.23% | Unkown |
| HY-N0670 | Tenacissoside H | Inhibitor | 99.89% | Unkown |
| HY-N0699 | Daphnoretin | 99.83% | Unkown | |
| HY-W009141 | 1-Monopalmitin | 99.89% | Unkown | |
| HY-11042 | GNE-477 | Inhibitor | 98.75% | Unkown |
| HY-107364 | MTX-211 | Inhibitor | 99.81% | Unkown |
| HY-118712 | WYE-23 | Inhibitor | 99.24% | Unkown |
| HY-121222 | alpha-Bisabolol | 80.0% | Unkown | |
| HY-128333 | PI3K/mTOR Inhibitor-4 | Inhibitor | 97.04% | Unkown |
| HY-165099 | C-8 Ceramide-1-phosphate | 99.0% | Unkown | |
| HY-174976 | FHND5032 | Inhibitor | 99.49% | Unkown |
| HY-N2445 | Flavokawain C | 99.79% | Unkown | |
| HY-N6064 | Polygalacin D | 99.95% | Unkown | |
| HY-W1126235 | DS02312223 | Activator | 98.24% | Unkown |
| HY-W130965 | 1-Formyl-beta-carboline | Inhibitor | 99.70% | Unkown |
| HY-136198 | SRX3207 | Inhibitor | 98.50% | Unkown |
| HY-108606 | PI-828 | Inhibitor | 99.62% | Unkown |
| HY-124652 | TBK1/IKKε-IN-4 | Inhibitor | 99.42% | Unkown |
| HY-150618 | PI3Kα-IN-9 | 98.78% | Unkown | |
| HY-153894 | SRX3177 | 99.33% | Unkown | |
| HY-157169 | IBL-302 | Inhibitor | 95.49% | Unkown |
| HY-178500A | WCY-8-67 TFA | 99.40% | Unkown | |
| HY-60298 | 6-Bromo-1H-indazole | 99.40% | Unkown | |
| HY-N0717S4 | L-Valine-1-13C | 99.75% | Unkown | |
| HY-N3000 | 6-Methoxydihydrosanguinarine | 99.88% | Unkown | |
| HY-P2196A | ELA-32(human) TFA | Agonist | 99.93% | Unkown |
| HY-W004121 | 4-Biphenylsulfonyl chloride | 99.59% | Unkown | |
| HY-Y1177 | Diphenyl disulfide | 99.96% | Unkown | |
| HY-15643A | LY 303511 hydrochloride | 98.87% | Unkown | |
| HY-167876 | PQR514 | 99.28% | Unkown | |
| HY-103224 | PIT-1 | Inhibitor | 98.08% | Unkown |
| HY-112613 | UCB9608 | Inhibitor | 99.59% | Unkown |
| HY-151622 | PI3K/mTOR Inhibitor-11 | Inhibitor | 99.65% | Unkown |
| HY-15868 | HS-173 | 99.04% | Unkown | |
| HY-13333 | NVP-BAG956 | Inhibitor | 99.21% | Unkown |
| HY-145526 | Hydroxy celecoxib | Activator | 98.71% | Unkown |
| HY-14971A | AKT inhibitor IV | Inhibitor | 99.40% | Unkown |
| HY-162382 | KTC1101 | Inhibitor | 98.09% | Unkown |
| HY-17508S1 | Clarithromycin-d3 | Inhibitor | 99.90% | Unkown |
| HY-181420A | BBO-11818 | 99.77% | Unkown | |
| HY-N0608 | Myrislignan | 99.53% | Unkown | |
| HY-N1103A | Vasicine hydrochloride | 98.62% | Unkown | |
| HY-N1967 | Dihydrocurcumin | Modulator | 99.58% | Unkown |
| HY-N3011 | Iridin | 99.72% | Unkown | |
| HY-N6017 | Bakkenolide A | 99.99% | Unkown | |
| HY-NP192 | Sericin | 0% | Unkown | |
| HY-10681R | Gedatolisib (Standard) | Inhibitor | 97.70% | Unkown |
| HY-12235 | PI-3065 | Inhibitor | 98.97% | Unkown |
| HY-15477A | YS-49 monohydrate | 99.56% | Unkown | |
| HY-120213 | YH-306 | 98.34% | Unkown | |
| HY-125847 | Salvianolic acid F | 99.50% | Unkown | |
| HY-143275 | HL-8 | Inhibitor | 99.17% | Unkown |
| HY-168608 | TRPM7-IN-1 | 98.83% | Unkown | |
| HY-176811 | VVD-442 | Inhibitor | 99.97% | Unkown |
| HY-19312S | 3-Methyladenine-d3 | 98.98% | Unkown | |
| HY-46866 | Isoegomaketone | 95.04% | Unkown | |
| HY-N0857 | Deoxyandrographolide | Activator | 98.0% | Unkown |
| HY-N0887 | Isoastragaloside I | 99.49% | Unkown | |
| HY-N2045 | Musk ketone | 99.21% | Unkown | |
| HY-N2590 | Lupenone | Inhibitor | 99.74% | Unkown |
| HY-N4246 | Bacopaside I | 99.20% | Unkown | |
| HY-N7695 | Physalin B | 97.20% | Unkown | |
| HY-NP203 | High density lipoprotein (human) | Activator | 98.00% | Unkown |
| HY-113402R | Gamma-glutamylcysteine (Standard) | 98.14% | Unkown | |
| HY-130687A | Psicose | 99.90% | Unkown | |
| HY-N0853A | Alisol A 24-acetate | 98.0% | Unkown | |
| HY-N2026S1 | Propylparaben-d4 | 99.55% | Unkown | |
| HY-13530 | CAY10505 | 99.75% | Unkown | |
| HY-136268 | AQX-435 | Activator | 99.15% | Unkown |
| HY-110193 | SPP-86 | Inhibitor | 99.87% | Unkown |
| HY-123952 | RTC-5 | Inhibitor | 99.37% | Unkown |
| HY-12895 | SKI V | 98.95% | Unkown | |
| HY-13514 | TG 100713 | Inhibitor | 99.21% | Unkown |
| HY-143403 | PI3K-IN-31 | Inhibitor | 99.33% | Unkown |
| HY-169212 | I194496 | Inhibitor | 98.52% | Unkown |
| HY-174461 | PROTAC PI3Kα degrader-1 | Degrader | 99.21% | Unkown |
| HY-N0728A | α-Linolenic acid sodium | Inhibitor | 96.67% | Unkown |
| HY-N1399 | Androsin | 99.94% | Unkown | |
| HY-N3720 | Demethoxycapillarisin | Inhibitor | 98.0% | Unkown |
| HY-N6841 | Rhodiolin | 98% | Unkown | |
| HY-N7363 | Isolongifolene | Inducer | 98.0% | Unkown |
| HY-W127575 | Cholesta-3,5-diene | Activator | 99.54% | Unkown |
| HY-118717 | mTOR inhibitor WYE-28 | Inhibitor | 99.75% | Unkown |
| HY-126049 | (S)-Oxiracetam | Inhibitor | 99.56% | Unkown |
| HY-20176 | 2,4-Dichlorothieno[3,2-d]pyrimidine | / | Unkown | |
| HY-10812 | GNE-490 | Inhibitor | 96.79% | Unkown |
| HY-18650 | KU 59403 | Inhibitor | 99.23% | Unkown |
| HY-11105 | Pilaralisib analogue | 99.74% | Unkown | |
| HY-111383 | LX2343 | 99.80% | Unkown | |
| HY-111510 | IPI-3063 | Inhibitor | 99.59% | Unkown |
| HY-112608 | CHMFL-PI3KD-317 | Inhibitor | 98.04% | Unkown |
| HY-132231 | FD223 | 98.05% | Unkown | |
| HY-147419 | Vulolisib | Inhibitor | 99.61% | Unkown |
| HY-107207 | Kaempferol 3-neohesperidoside | 99.68% | Unkown | |
| HY-131502 | Taspine | Inhibitor | 98.0% | Unkown |
| HY-133907 | NVS-PI3-4 | Inhibitor | 99.40% | Unkown |
| HY-144993 | PI3Kδ/γ-IN-1 | Inhibitor | 99.39% | Unkown |
| HY-15271 | WYE-687 | Inhibitor | 98.05% | Unkown |
| HY-161366 | OMS14 | Inhibitor | 99.09% | Unkown |
| HY-163853 | Antidiabetic agent 6 | Activator | 99.97% | Unkown |
| HY-168906 | BI-113823 | 99.23% | Unkown | |
| HY-176812 | VVD-849 | 99.76% | Unkown | |
| HY-19341 | Compound 401 | Inhibitor | 99.97% | Unkown |
| HY-N0143A | Phlorizin dihydrate | 99.51% | Unkown | |
| HY-N0761A | trans-Isoferulic acid | 99.93% | Unkown | |
| HY-N2000 | Bellidifolin | Modulator | 99.74% | Unkown |
| HY-N2911 | Auriculasin | 98.58% | Unkown | |
| HY-N3035 | Tetrahydroepiberberine | Inhibitor | 99.38% | Unkown |
| HY-N5136 | 25(R,S)-Ruscogenin | Inhibitor | 99.83% | Unkown |
| HY-N6896 | Isoviolanthin | Inhibitor | 99.87% | Unkown |
| HY-N6932 | Voacamine | 99.64% | Unkown | |
| HY-W005308 | N-BOC-DL-serine methyl ester | 98.0% | Unkown | |
| HY-120265 | MIPS-9922 | Inhibitor | 99.25% | Unkown |
| HY-122949 | Momordicine I | 97.0% | Unkown | |
| HY-12340 | ETP-46321 | Inhibitor | 99.34% | Unkown |
| HY-101776A | Desmethyl-VS-5584 hydrochloride | Inhibitor | 98.63% | Unkown |
| HY-146223 | AZD4625 | 98.44% | Unkown | |
| HY-101921 | PI3Kδ-IN-1 | Inhibitor | 99.60% | Unkown |
| HY-131345 | PI3Kα-IN-4 | Inhibitor | 99.76% | Unkown |
| HY-131345A | (S)-PI3Kα-IN-4 | Inhibitor | 99.77% | Unkown |
| HY-133124 | PARP/PI3K-IN-1 | 99.40% | Unkown | |
| HY-B0965AS | Thioridazine-d3 hydrochloride | 98.25% | Unkown | |
| HY-100603A | (S)-GSK-F1 | Inhibitor | 98.01% | Unkown |
| HY-10620 | PI3K-IN-22 | Inhibitor | 99.50% | Unkown |
| HY-10681S | Gedatolisib-d8 | / | Unkown | |
| HY-110109 | ETP-45658 | Inhibitor | 98.97% | Unkown |
| HY-111209 | Pichromene | Inhibitor | 98.7% | Unkown |
| HY-118521 | AS-041164 | Inhibitor | 99.02% | Unkown |
| HY-124535 | TGX-115 | Inhibitor | 99.31% | Unkown |
| HY-124834 | Nrf2 activator-10 | 98.65% | Unkown | |
| HY-12652 | AZD3147 | Inhibitor | 99.93% | Unkown |
| HY-130307 | Rubrofusarin | Inhibitor | 98.19% | Unkown |
| HY-137340 | WH-10417-099 | Degrader | 98.14% | Unkown |
| HY-147284 | PI3K-IN-37 | Inhibitor | 99.0% | Unkown |
| HY-150019 | PI3K-IN-36 | Inhibitor | 98.76% | Unkown |
| HY-153120A | PI3K/mTOR Inhibitor-13 sodium | Inhibitor | 98.11% | Unkown |
| HY-153306A | (S)-Zovegalisib | Control | 99.89% | Unkown |
| HY-155066 | FD274 | 99.45% | Unkown | |
| HY-157704 | 18:1 PI(3)P | 99% | Unkown | |
| HY-163299 | pan-KRAS-IN-5 | 96.70% | Unkown | |
| HY-174798 | PI3Kα Ligand-1 | Ligand | 98.0% | Unkown |
| HY-180261 | GP262 | 98.43% | Unkown | |
| HY-18085S | Quercetin-d5 | 96.72% | Unkown | |
| HY-B0633E | Hyaluronic acid, low endotoxin | / | Unkown | |
| HY-N0427 | Phellodendrine | 99.60% | Unkown | |
| HY-N12044 | Asparanin A | Inducer | / | Unkown |
| HY-N12124 | Monascuspiloin | 95% | Unkown | |
| HY-N1904 | 4′-Hydroxywogonin | 98.22% | Unkown | |
| HY-N4042 | Hirsutenone | Inhibitor | 99.74% | Unkown |
| HY-N7635 | Oleanolic acid 28-O-β-D-glucopyranoside | 99.42% | Unkown | |
| HY-N8884 | Coelonin | Inhibitor | 98.0% | Unkown |
| HY-P6292 | KS-133 | 98.75% | Unkown | |
| HY-W049881 | 9-Methyl-β-carboline | 99.86% | Unkown | |
| HY-W713284 | 2-Ethylhexyl (E)-3-(4-(methoxy-d3)phenyl)acrylate | 99.87% | Unkown | |
| HY-12338 | ON 146040 | Inhibitor | 95.05% | Unkown |
| HY-155520 | Antileishmanial agent-19 | Inhibitor | 99.45% | Unkown |
| HY-156872 | MTX-216 | / | Unkown | |
| HY-50673A | Dactolisib hydrochloride | 99.41% | Unkown | |
| HY-N0565S1 | Doxycycline-d3 (hyclate) (major) | 95.10% | Unkown | |
| HY-N0728S | α-Linolenic acid-d5 | Inhibitor | 99.9% | Unkown |
| HY-N6739S | Beauvericin-13C45 | Inhibitor | ≥99% | Unkown |
| HY-101517 | PI3K-IN-2 | Inhibitor | 99.62% | Unkown |
| HY-178500 | WCY-8-67 | / | Unkown | |
| HY-131910 | IHMT-PI3Kδ-372 | Inhibitor | 99.69% | Unkown |
| HY-101517A | (S)-PI3K-IN-2 | Inhibitor | 99.50% | Unkown |
| HY-103030 | PI3K-IN-32 | Inhibitor | 99.7% | Unkown |
| HY-108418A | (R)-PI3Kδ-IN-15 | Control | 99.52% | Unkown |
| HY-109633 | PI3K/mTOR-IN-23 | Inhibitor | 99.0% | Unkown |
| HY-109633A | PI3K/mTOR-IN-23 dihydrochloride | Inhibitor | 99.70% | Unkown |
| HY-112172 | Tenalisib R Enantiomer | 99.63% | Unkown | |
| HY-113308S1 | Taurolithocholic acid-d4 | 98.36% | Unkown | |
| HY-120438 | TASP0415914 | Inhibitor | 99.02% | Unkown |
| HY-123849 | SN32976 | Inhibitor | 99.49% | Unkown |
| HY-125542 | DCZ3301 | 99.73% | Unkown | |
| HY-132276 | PtdIns-(3,4,5)-P3-biotin sodium | 98.0% | Unkown | |
| HY-13504 | PIK-293 | Inhibitor | 99.41% | Unkown |
| HY-136512 | Streptazolin | 98.65% | Unkown | |
| HY-13864 | PF-4989216 | 99.38% | Unkown | |
| HY-147768 | PI3K/AKT-IN-2 | 98.10% | Unkown | |
| HY-15271A | WYE-687 dihydrochloride | Inhibitor | ≥98.0% | Unkown |
| HY-155232 | PI3Kδ-IN-16 | 99.02% | Unkown | |
| HY-16122B | CAL-130 Hydrochloride | Inhibitor | 98.74% | Unkown |
| HY-17635S | Leniolisib-d5 | Inhibitor | 98.78% | Unkown |
| HY-18085AS | Quercetin-d3 hydrate | 96.44% | Unkown | |
| HY-183068 | AP4-43 | Inhibitor | / | Unkown |
| HY-203618 | PI3K/mTOR ligand-1 | Ligand | 97.28% | Unkown |
| HY-N0430 | Coptisine | / | Unkown | |
| HY-N0451R | Acacetin (Standard) | Inducer | 98.19% | Unkown |
| HY-N0728S2 | α-Linolenic acid-d14 | Inhibitor | / | Unkown |
| HY-N10144 | Shinpterocarpin | Inhibitor | / | Unkown |
| HY-N2051 | Zeylenone | Activator | 98.0% | Unkown |
| HY-N2199 | Sotetsuflavone | 96.75% | Unkown | |
| HY-N3260 | Methyllucidone | 98.0% | Unkown | |
| HY-N3542 | Carpachromene | Inhibitor | 98.84% | Unkown |
| HY-N6580 | Ginsenoside Rg4 | 99.94% | Unkown | |
| HY-W010201R | Citronellol (Standard) | 97.16% | Unkown | |
| HY-W040417 | Boc-L-cyclobutylglycine | 98.91% | Unkown | |
| HY-Y1322S | Triphenyl phosphate-d15 | 99.74% | Unkown | |
| HY-108418 | PI3Kδ-IN-15 | Inhibitor | 99.52% | Unkown |
| HY-15174R | Dactolisib Tosylate (Standard) | 98.95% | Unkown | |
| HY-15872 | FTI-277 | / | Unkown | |
| HY-16355 | NVP-QAV-572 | Inhibitor | 98.53% | Unkown |
| HY-176422 | (S,R,S)-AHPC-Amide-PEG2-C2-NH2 | 97.16% | Unkown | |
| HY-N0265R | Asperosaponin VI (Standard) | Inhibitor | 99.46% | Unkown |
| HY-N2026A | Propylparaben sodium | 99.03% | Unkown | |
| HY-N2026R | Propylparaben (Standard) | 99.81% | Unkown | |
| HY-U00326 | PI3Kα/mTOR-IN-1 | Inhibitor | 99.30% | Unkown |
| HY-W075770 | Nickel(II) oxide | ≥99.0% | Unkown | |
| HY-101798 | MDVN1003 | Inhibitor | / | Unkown |
| HY-142646 | PI3Kδ-IN-9 | Inhibitor | / | Unkown |
| HY-144876 | RIDR-PI-103 | Inducer | 98.02% | Unkown |
| HY-18085S2 | Quercetin-13C3 | / | Unkown | |
| HY-101114 | LAS191954 | Inhibitor | / | Unkown |
| HY-112602 | PI3K/mTOR Inhibitor-1 | Inhibitor | / | Unkown |
| HY-113308AS | Taurolithocholic acid-d4 sodium | 99.4% | Unkown | |
| HY-128582 | PI3K/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-132880 | GSK251 | Inhibitor | 99.88% | Unkown |
| HY-134472 | PI3Kδ-IN-8 | Inhibitor | / | Unkown |
| HY-141876 | PRT543 | / | Unkown | |
| HY-151137 | HSP90/mTOR-IN-1 | / | Unkown | |
| HY-B1203S | Fludrocortisone-d5 | / | Unkown | |
| HY-N0565AS | Doxycycline-d3 (hydrochloride) | / | Unkown | |
| HY-N0565S3 | Doxycycline-13C,d3 | / | Unkown | |
| HY-100424 | PI3K-IN-63 | Inhibitor | / | Unkown |
| HY-101115 | PI3K-IN-6 | Inhibitor | / | Unkown |
| HY-112286 | PI3Kγ inhibitor 2 | Inhibitor | / | Unkown |
| HY-112439 | PI3Kdelta inhibitor 1 | Inhibitor | / | Unkown |
| HY-112614 | ATM Inhibitor-1 | Inhibitor | / | Unkown |
| HY-118903 | PIK-124 | Inhibitor | / | Unkown |
| HY-132299 | PI3Kγ inhibitor 4 | Inhibitor | / | Unkown |
| HY-132807 | Amdizalisib | Inhibitor | / | Unkown |
| HY-133029 | PI3K-IN-9 | Inhibitor | / | Unkown |
| HY-162878 | CHF-6523 | Inhibitor | / | Unkown |
| HY-174366 | JMC14 | Inhibitor | / | Unkown |
| HY-10109A | AS-605240 potassium | Inhibitor | / | Unkown |
| HY-101145 | CK37 | Inhibitor | / | Unkown |
| HY-10116 | PI-540 | Inhibitor | / | Unkown |
| HY-101776 | Desmethyl-VS-5584 | Inhibitor | / | Unkown |
| HY-105666 | TGX-155 | Inhibitor | / | Unkown |
| HY-106006 | RV-1729 | Inhibitor | / | Unkown |
| HY-10681S1 | Gedatolisib-d6 | Inhibitor | / | Unkown |
| HY-107387 | PF-376304 | Inhibitor | / | Unkown |
| HY-108958 | (Rac)-AZD8186 | Inhibitor | / | Unkown |
| HY-108959 | D-87503 | Inhibitor | / | Unkown |
| HY-109198A | Zandelisib hydrochloride | Inhibitor | / | Unkown |
| HY-111058 | D-106669 | Inhibitor | / | Unkown |
| HY-111137 | Puquitinib | Inhibitor | / | Unkown |
| HY-111172 | Inotilone | Inhibitor | 95.26% | Unkown |
| HY-112191 | PI3K-IN-10 | Inhibitor | / | Unkown |
| HY-113308AS2 | Taurolithocholic acid-d4-1 sodium | / | Unkown | |
| HY-113308S | Taurolithocholic acid-d5 | / | Unkown | |
| HY-113572 | PX-866-17OH | Inhibitor | / | Unkown |
| HY-113817 | SHIP1 activator 1 | / | Unkown | |
| HY-114923 | SU-11752 | Inhibitor | / | Unkown |
| HY-115814 | AM-1430 | Inhibitor | / | Unkown |
| HY-116431 | I-BOP | Agonist | / | Unkown |
| HY-116497 | PH11 | Inhibitor | / | Unkown |
| HY-116604 | RLX | Inhibitor | / | Unkown |
| HY-116604A | RLX hydrochloride | Inhibitor | / | Unkown |
| HY-116882 | PIK-39 | Inhibitor | / | Unkown |
| HY-118160 | PPM-18 | 99.17% | Unkown | |
| HY-120116 | AM-8508 | Inhibitor | / | Unkown |
| HY-120135 | LTURM 36 | Inhibitor | / | Unkown |
| HY-120281 | ST-168 | / | Unkown | |
| HY-121012 | (rac)-AG-205 | / | Unkown | |
| HY-12279F | Umbralisib R-enantiomer | Inhibitor | 99.52% | Unkown |
| HY-123862 | LAS195319 | Inhibitor | / | Unkown |
| HY-124615 | ST-162 | Antagonist | / | Unkown |
| HY-124647 | PI3Kα-IN-1 | Inhibitor | / | Unkown |
| HY-12482 | X-370 | / | Unkown | |
| HY-125376 | PI3Kδ-IN-3 | Inhibitor | / | Unkown |
| HY-126083 | 17β-Hydroxywortmannin | Inhibitor | / | Unkown |
| HY-128027 | eCF309 | Inhibitor | 98.2% | Unkown |
| HY-128393S2 | Trilinolein-d5 | / | Unkown | |
| HY-128633 | DHW-208 | / | Unkown | |
| HY-128634 | Anticancer agent 164 | / | Unkown | |
| HY-128741S | D-Allose-13C | / | Unkown | |
| HY-128741S1 | D-Allose-13C-1 | / | Unkown | |
| HY-128741S2 | D-Allose-13C-2 | / | Unkown | |
| HY-130133 | DHW-221 | / | Unkown | |
| HY-131055 | Mytoxin B | / | Unkown | |
| HY-131910A | (R)-IHMT-PI3Kδ-372 | Inhibitor | 99.75% | Unkown |
| HY-132898 | PI3K-IN-23 | Activator | / | Unkown |
| HY-135526 | Demethoxyviridiol | Inhibitor | / | Unkown |
| HY-136806 | PI3K-IN-12 | Inhibitor | / | Unkown |
| HY-13685S1 | Miltefosine-d4 | Inhibitor | / | Unkown |
| HY-138302 | PF-06862309 | / | Unkown | |
| HY-139832 | MCX 28 | Inhibitor | / | Unkown |
| HY-139880 | PI3Kγ inhibitor 5 | Inhibitor | / | Unkown |
| HY-141476 | PI3K/mTOR Inhibitor-3 | Inhibitor | / | Unkown |
| HY-14153S | Tegaserod-d11 | / | Unkown | |
| HY-141690A | PI3K-IN-19 hydrochloride | Inhibitor | / | Unkown |
| HY-142676 | PI3K-IN-26 | Inhibitor | / | Unkown |
| HY-142677 | PI3K-IN-27 | / | Unkown | |
| HY-143277 | HL-2 | / | Unkown | |
| HY-143472 | PI3Kδ-IN-11 | / | Unkown | |
| HY-144059 | AKT-IN-9 | Inhibitor | / | Unkown |
| HY-144060 | AKT-IN-10 | Inhibitor | / | Unkown |
| HY-144224S | Tianeptine-d6 hydrochloride | / | Unkown | |
| HY-144254 | PI3Kδ-IN-10 | / | Unkown | |
| HY-144295 | PI3Kα-IN-5 | Inhibitor | / | Unkown |
| HY-144450 | PI3K-IN-29 | Inhibitor | / | Unkown |
| HY-144686 | ATM Inhibitor-3 | Inhibitor | / | Unkown |
| HY-144687 | ATM Inhibitor-4 | Inhibitor | / | Unkown |
| HY-144692 | MEK/PI3K-IN-1 | Inhibitor | / | Unkown |
| HY-144693 | MEK/PI3K-IN-2 | Inhibitor | / | Unkown |
| HY-145338 | PI3Kβ-IN-1 | Inhibitor | / | Unkown |
| HY-145358 | FAP-PI3KI1 | Inhibitor | / | Unkown |
| HY-145432 | PI3K-IN-28 | Inhibitor | / | Unkown |
| HY-146016 | PI3K/mTOR Inhibitor-5 | Inhibitor | / | Unkown |
| HY-146159 | PI3K/HDAC-IN-2 | Inhibitor | / | Unkown |
| HY-146200 | PI3K/mTOR Inhibitor-8 | Inhibitor | / | Unkown |
| HY-146223A | (3R,10R,14aS)-AZD4625 | 98.00% | Unkown | |
| HY-146260 | NVP-CLR457 | Inhibitor | / | Unkown |
| HY-146504 | Topoisomerase I/II inhibitor 3 | / | Unkown | |
| HY-146743 | Antitumor agent-53 | Inducer | / | Unkown |
| HY-146789 | PI3Kδ/γ-IN-2 | Inhibitor | / | Unkown |
| HY-146835S | (Rac)-16:0PI(3,5)P2-d5 ammonium | / | Unkown | |
| HY-147285 | PI3K/mTOR Inhibitor-9 | Inhibitor | / | Unkown |
| HY-147567 | ATR-IN-15 | Inhibitor | / | Unkown |
| HY-147613 | PI3K/mTOR Inhibitor-6 | Inhibitor | / | Unkown |
| HY-147614 | PI3K/mTOR Inhibitor-7 | Inhibitor | / | Unkown |
| HY-147767 | PI3Kα-IN-6 | / | Unkown | |
| HY-147792 | WNY1613 | Inhibitor | / | Unkown |
| HY-147898 | PI3K-IN-33 | / | Unkown | |
| HY-147899 | PI3K-IN-34 | / | Unkown | |
| HY-147900 | PI3K-IN-35 | / | Unkown | |
| HY-147911 | COX-2/PI3K-IN-1 | Inhibitor | / | Unkown |
| HY-147912 | COX-2/PI3K-IN-2 | Inhibitor | / | Unkown |
| HY-147913 | PI3K/Akt/mTOR-IN-3 | / | Unkown | |
| HY-147966 | HDAC-IN-43 | Inhibitor | / | Unkown |
| HY-147983 | PI3Kα-IN-8 | / | Unkown | |
| HY-148317 | PI3Kγ inhibitor 6 | Inhibitor | / | Unkown |
| HY-148972 | PI(3,5)P2 diC16 | / | Unkown | |
| HY-149000 | PI3Kα-IN-7 | / | Unkown | |
| HY-149092 | Anticancer agent 109 | / | Unkown | |
| HY-149205 | CXJ-2 | Inhibitor | / | Unkown |
| HY-149235 | PI3Kδ-IN-12 | Inhibitor | / | Unkown |
| HY-149427 | PI3Kα-IN-12 | Inhibitor | / | Unkown |
| HY-149472 | Anti-osteoporosis agent-4 | Inhibitor | / | Unkown |
| HY-149493 | IHMT-PI3K-455 | Inhibitor | / | Unkown |
| HY-149521 | PI3K-IN-47 | Inhibitor | / | Unkown |
| HY-149539 | PLM-101 | Inhibitor | / | Unkown |
| HY-149556 | MTX-241F | Inhibitor | / | Unkown |
| HY-149634 | PI3Kδ-IN-17 | Inhibitor | / | Unkown |
| HY-150034 | PI3K-IN-38 | Inhibitor | / | Unkown |
| HY-150061 | NVP-BBD130 | Inhibitor | / | Unkown |
| HY-150587 | Anti-inflammatory agent 31 | Inhibitor | / | Unkown |
| HY-150638 | PI3Kδ/γ-IN-3 | / | Unkown | |
| HY-151635 | PI3K/VEGFR2-IN-1 | / | Unkown | |
| HY-151915 | ATR-IN-20 | Inhibitor | / | Unkown |
| HY-152238 | PI3K/mTOR Inhibitor-12 | Inhibitor | / | Unkown |
| HY-15244G | Alpelisib (GMP) | / | Unkown | |
| HY-15268 | PP487 | Inhibitor | / | Unkown |
| HY-152774 | Antitumor agent-86 | Inhibitor | / | Unkown |
| HY-153120 | PI3K/mTOR Inhibitor-13 | Inhibitor | / | Unkown |
| HY-153703 | PI3Kγ inhibitor 7 | Inhibitor | / | Unkown |
| HY-153915 | PI3Kα-IN-11 | Inhibitor | 95.35% | Unkown |
| HY-155124 | Antiproliferative agent-32 | Inducer | / | Unkown |
| HY-155180 | FD2056 | Inhibitor | / | Unkown |
| HY-155570 | Anticancer agent 137 | / | Unkown | |
| HY-155730 | PI3K-IN-41 | Inhibitor | / | Unkown |
| HY-155833 | PI3Kδ-IN-13 | Inhibitor | / | Unkown |
| HY-155890 | Fimepinostat mesylate | / | Unkown | |
| HY-155975 | PI3Kδ-IN-14 | Inhibitor | / | Unkown |
| HY-155996 | FD2157 | / | Unkown | |
| HY-156018 | PI3Kα-IN-13 | Inhibitor | / | Unkown |
| HY-156080 | PI3K-IN-48 | Inhibitor | / | Unkown |
| HY-156091 | PI3Kα/HDAC6-IN-1 | Inhibitor | / | Unkown |
| HY-15643B | LY 303511 dihydrochloride | / | Unkown | |
| HY-156445 | PI3K/mTOR Inhibitor-14 | Inhibitor | / | Unkown |
| HY-157125 | PI3Kα-IN-14 | / | Unkown | |
| HY-157128 | PI3Kδ-IN-18 | Inhibitor | / | Unkown |
| HY-157295 | PI3K/HDAC-IN-3 | Inhibitor | / | Unkown |
| HY-157319 | PI3Kα-IN-15 | Inhibitor | / | Unkown |
| HY-157648 | 18:0-20:4 PI(3)P ammonium | / | Unkown | |
| HY-157652 | 18:0-20:4 PI(3,4,5)P3 | / | Unkown | |
| HY-157707 | 18:1 PI(3,4,5)P3 | / | Unkown | |
| HY-157714 | 08:0 PI(3,4)P2 | / | Unkown | |
| HY-158017 | WXM-1-170 | / | Unkown | |
| HY-158029 | PI3Kα-IN-21 | / | Unkown | |
| HY-158050 | PXB17 | Inhibitor | / | Unkown |
| HY-158147 | PI3Kδ-IN-20 | Inhibitor | / | Unkown |
| HY-158156 | NF-κB-IN-16 | / | Unkown | |
| HY-158688 | PI3Kδ-IN-21 | Inhibitor | / | Unkown |
| HY-159510 | VEGFR-2-IN-51 | / | Unkown | |
| HY-159517 | PI3K/Akt/mTOR-IN-5 | / | Unkown | |
| HY-159577 | Nic-15 | Modulator | / | Unkown |
| HY-159892 | PD-1/PD-L1-IN-54 | / | Unkown | |
| HY-160099S | 20-5,14-HEDE-d2 | / | Unkown | |
| HY-160099S1 | 20-5,14-HEDE-d2-1 | / | Unkown | |
| HY-160099S2 | 20-5,14-HEDE-d2-2 | / | Unkown | |
| HY-160282 | PI3K-IN-49 | Inhibitor | / | Unkown |
| HY-160283 | PI3K-IN-50 | Inhibitor | / | Unkown |
| HY-160418 | PI3K-IN-51 | Inhibitor | / | Unkown |
| HY-160864 | Torbafylline | Inhibitor | / | Unkown |
| HY-161140 | PI3Kα-IN-16 | Inhibitor | / | Unkown |
| HY-161144 | AKT-IN-21 | / | Unkown | |
| HY-161301 | PI3K-IN-52 | Inhibitor | / | Unkown |
| HY-161362 | SR-3-65 | / | Unkown | |
| HY-161373 | PI3Kα-IN-22 | Inhibitor | / | Unkown |
| HY-161816 | PI3K/AKT-IN-3 | / | Unkown | |
| HY-161852 | PI3K-IN-55 | / | Unkown | |
| HY-161858 | EpskA21 | / | Unkown | |
| HY-161874 | RPS6-IN-1 | / | Unkown | |
| HY-161968 | EGFR/PI3Kα-IN-1 | Inhibitor | / | Unkown |
| HY-162268 | MALT1-IN-13 | / | Unkown | |
| HY-162292 | Anticancer agent 190 | Inhibitor | / | Unkown |
| HY-162647 | PI3Kδ-IN-22 | Inhibitor | / | Unkown |
| HY-162802 | PI3K/AKT-IN-4 | / | Unkown | |
| HY-162848 | IHMT-PI3K-315 | Inhibitor | / | Unkown |
| HY-163151 | JE-133 | Inhibitor | / | Unkown |
| HY-16332 | ML-220 | / | Unkown | |
| HY-163360 | PI3Kα-IN-19 | Inhibitor | / | Unkown |
| HY-163361 | PI3Kα-IN-20 | Inhibitor | / | Unkown |
| HY-163501 | PI3Kα-IN-23 | Inhibitor | / | Unkown |
| HY-163511 | PI3K/Akt/mTOR-IN-4 | / | Unkown | |
| HY-163533 | CPD-002 | Inhibitor | / | Unkown |
| HY-163538 | TYM-3-98 | 99.56% | Unkown | |
| HY-16461 | Solenopsin | / | Unkown | |
| HY-165394 | Melafolone | Inhibitor | / | Unkown |
| HY-16769 | Panulisib | / | Unkown | |
| HY-168319 | PI3Kγ ligand 1 | / | Unkown | |
| HY-168609 | CRI9 | / | Unkown | |
| HY-168718 | FAK-IN-22 | / | Unkown | |
| HY-168858 | TRK-IN-30 | Inhibitor | / | Unkown |
| HY-168893 | K882 | / | Unkown | |
| HY-168919 | KRASG12C IN-16 | / | Unkown | |
| HY-169019 | XJTU-L453 | / | Unkown | |
| HY-169100 | Antiproliferative agent-57 | Inhibitor | / | Unkown |
| HY-169403 | NW16 | / | Unkown | |
| HY-169413 | AKT-IN-25 | Inhibitor | / | Unkown |
| HY-169983 | PI3Kδ-IN-23 | Inhibitor | / | Unkown |
| HY-170648 | TS-IN-5 | / | Unkown | |
| HY-170656 | PI3K/mTOR Inhibitor-17 | Inhibitor | / | Unkown |
| HY-170877 | SHP2-IN-35 | / | Unkown | |
| HY-170912 | Topo I/II-IN-2 | / | Unkown | |
| HY-171558 | PI3K-IN-56 | Inhibitor | / | Unkown |
| HY-171777 | Erufosine | Inhibitor | / | Unkown |
| HY-172130 | PI3Kδ/BET-IN-1 | Inhibitor | / | Unkown |
| HY-172139 | PI3Kα-IN-25 | Inhibitor | / | Unkown |
| HY-172175 | HYS-072 | / | Unkown | |
| HY-172201 | NF-κB-IN-19 | / | Unkown | |
| HY-172255 | PI4KIII beta inhibitor 4 | / | Unkown | |
| HY-172256 | PI4KIII beta inhibitor 5 | Inhibitor | / | Unkown |
| HY-172259 | Toyaburgine | Inhibitor | / | Unkown |
| HY-172620 | LIB3S0280 | 99.89% | Unkown | |
| HY-172771 | Multi-target kinase inhibitor 4 | Inhibitor | / | Unkown |
| HY-172784 | Anticancer agent 273 | / | Unkown | |
| HY-172785 | PI3K-IN-57 | Inhibitor | / | Unkown |
| HY-172886 | PI3K-IN-58 | / | Unkown | |
| HY-172889 | PI3K/HDAC-IN-4 | / | Unkown | |
| HY-172892 | PI3K-IN-59 | Inhibitor | / | Unkown |
| HY-172964 | KIM-161 | / | Unkown | |
| HY-173005 | JZ19 | Inhibitor | / | Unkown |
| HY-173007 | ALK/PI3K/AKT-IN-1 | / | Unkown | |
| HY-173165 | OA-Br-1 | / | Unkown | |
| HY-173367 | Anticancer agent 271 | Inhibitor | / | Unkown |
| HY-173368 | Antiproliferative agent-67 | Inhibitor | / | Unkown |
| HY-173493 | ALK-IN-31 | / | Unkown | |
| HY-174306 | MARY1 | / | Unkown | |
| HY-174321 | A2073 | Inhibitor | / | Unkown |
| HY-174324 | VEGFR-2/P-gp-IN-1 | / | Unkown | |
| HY-174379 | KRAS IN-44 | / | Unkown | |
| HY-174396 | PI3Kδ/HDAC6-IN-1 | / | Unkown | |
| HY-174469 | PROTAC PI3K/110β degrader-2 | / | Unkown | |
| HY-174855 | PI3K/mTOR-IN-17 | / | Unkown | |
| HY-175002 | PI3Kδ-IN-24 | / | Unkown | |
| HY-175068 | D-myo-Inositol-1,3,4,5,6-pentaphosphate sodium | / | Unkown | |
| HY-175317 | Nogo-B-IN-1 | / | Unkown | |
| HY-175369 | PI3Kδ-IN-25 | Inhibitor | / | Unkown |
| HY-175734 | PI3Kδ-IN-26 | Inhibitor | / | Unkown |
| HY-175874 | Tubulin-IN-55 | / | Unkown | |
| HY-176239 | PROTAC PI3Kδ degrader-1 | / | Unkown | |
| HY-176281 | PI3Kα-IN-26 | Inhibitor | / | Unkown |
| HY-176421 | PROTAC PI3K/110β degrader-1 | Degrader | / | Unkown |
| HY-17651 | PI3K-IN-60 | Inhibitor | / | Unkown |
| HY-176854 | PI3K/mTOR-IN-18 | Inhibitor | / | Unkown |
| HY-177149 | Allantoin ascorbate | / | Unkown | |
| HY-177270 | CHNQD-01281 | Modulator | / | Unkown |
| HY-177277 | HM5023507 | Inhibitor | / | Unkown |
| HY-177277A | (R)-HM5023507 | Inhibitor | / | Unkown |
| HY-177762 | Pan-RAS-IN-8 | Inhibitor | / | Unkown |
| HY-177908 | SH-273 | / | Unkown | |
| HY-178304S | L-Valine-d7 | / | Unkown | |
| HY-178305S | L-Valine-d | / | Unkown | |
| HY-178371 | PI3KC2γ-IN-1 | Inhibitor | / | Unkown |
| HY-178485 | SJY26 | Inhibitor | / | Unkown |
| HY-178812 | PI3Kα-IN-27 | / | Unkown | |
| HY-178955 | EGFR-IN-182 | / | Unkown | |
| HY-178984 | PI3Kα-IN-28 | / | Unkown | |
| HY-178993 | PI3K/AKT-IN-5 | / | Unkown | |
| HY-178996 | FLT3-IN-36 | / | Unkown | |
| HY-179032 | VEGFR-2-IN-77 | / | Unkown | |
| HY-179155 | PI3K/mTOR-IN-19 | / | Unkown | |
| HY-179424 | PROTAC HIF-1α degrader-2 | / | Unkown | |
| HY-179457 | CC-11 | Inhibitor | / | Unkown |
| HY-179464 | CC-M-1 | Inhibitor | / | Unkown |
| HY-179498 | ROCK2-IN-13 | / | Unkown | |
| HY-179623 | PI3Kα-IN-29 | / | Unkown | |
| HY-180112 | SH543 | / | Unkown | |
| HY-180192 | Dehydroxy-oridonin-vinyl ester | / | Unkown | |
| HY-180281 | PLAGL2-IN-1 | / | Unkown | |
| HY-180556 | PI3K/mTOR-IN-20 | Inhibitor | / | Unkown |
| HY-180853 | PI3K/Akt/mTOR-IN-6 | / | Unkown | |
| HY-181015 | α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu | / | Unkown | |
| HY-181093 | EGFR-IN-191 | / | Unkown | |
| HY-181097 | EGFR-IN-192 | / | Unkown | |
| HY-181099 | EGFR WT/T790M-IN-4 | / | Unkown | |
| HY-181150 | Hit20 | Inhibitor | / | Unkown |
| HY-181153 | PROTAC FGFR3 Degrader-1 | Degrader | / | Unkown |
| HY-181420 | (S,R,S)-BBO-11818 | / | Unkown | |
| HY-181479 | EGFR-IN-196 | / | Unkown | |
| HY-181581 | IMM-H012 | Inhibitor | / | Unkown |
| HY-181670 | WH23 | / | Unkown | |
| HY-181672 | PI3K/AKT/ERK/CREB activator 1 | Activator | / | Unkown |
| HY-181710 | LASSBio-2337 | Inhibitor | / | Unkown |
| HY-181741 | PI3K-001 | / | Unkown | |
| HY-181801 | FASN-IN-8 | / | Unkown | |
| HY-181833 | PI3K/PIKK-IN-1 | Inhibitor | / | Unkown |
| HY-181855 | PI3K/PIKK-IN-2 | Inhibitor | / | Unkown |
| HY-181883 | KRAS-IN-55 | Inhibitor | / | Unkown |
| HY-182003 | Anticancer agent 308 | / | Unkown | |
| HY-182066 | Photosensitizer-9 | Activator | / | Unkown |
| HY-182083 | PROTAC PI3Kα/δ degrader-1 | Degrader | / | Unkown |
| HY-182086 | Copanlisib-NH | Ligand | / | Unkown |
| HY-182236 | JRN73958 | / | Unkown | |
| HY-182282 | PI3K/AKT-IN-6 | Inhibitor | / | Unkown |
| HY-182368 | PI3Kα-IN-30 | / | Unkown | |
| HY-182614 | BJ-2302 | Inhibitor | / | Unkown |
| HY-182671 | SRX3305 | / | Unkown | |
| HY-182693 | CPL302-253 | Inhibitor | / | Unkown |
| HY-182946 | PI3Kα-IN-31 | Inhibitor | / | Unkown |
| HY-183069 | FKL-137 | / | Unkown | |
| HY-183272 | PI3K/Akt/mTOR-IN-7 | Inhibitor | / | Unkown |
| HY-183285 | PI3Kα-IN-32 | Inhibitor | / | Unkown |
| HY-183316 | Anticancer agent 319 | / | Unkown | |
| HY-183327 | PI3K/mTOR-IN-22 | Inhibitor | / | Unkown |
| HY-183741 | VVD-844 | Inhibitor | / | Unkown |
| HY-183770 | LCI40 | Inhibitor | / | Unkown |
| HY-183787 | PI3Kα-IN-33 | / | Unkown | |
| HY-183922 | SRX3212 | Inhibitor | / | Unkown |
| HY-184001 | LT-1339-553 | Inhibitor | / | Unkown |
| HY-184119 | Pabgraminone C | / | Unkown | |
| HY-184125 | PI3Kδ-IN-28 | Inhibitor | / | Unkown |
| HY-184167 | COH-19 | / | Unkown | |
| HY-184303 | Antihypertensive agent 7 | Activator | / | Unkown |
| HY-184311 | EGFR-IN-214 | / | Unkown | |
| HY-184321 | LC-MG-5 | / | Unkown | |
| HY-184322 | LC-MG-10 | / | Unkown | |
| HY-184385 | PI3K/AKT/JAK2-IN-1 | Inhibitor | / | Unkown |
| HY-184412 | SDUY104 | / | Unkown | |
| HY-185205 | VVD-484 | Inhibitor | / | Unkown |
| HY-185460 | Pertuzumab-LD3 | Inhibitor | / | Unkown |
| HY-19535B | Nemiralisib succinate | Inhibitor | / | Unkown |
| HY-19719B | Miransertib mesylate | Inhibitor | / | Unkown |
| HY-48869 | PI3K-IN-46 | 98.0% | Unkown | |
| HY-B0093AS | Benazepril-d5 hydrochloride | Inhibitor | / | Unkown |
| HY-B1203S1 | Fludrocortisone-d2 | / | Unkown | |
| HY-B1550S | Benzoin-d10 | Inhibitor | / | Unkown |
| HY-B1885S | Fenitrothion-d6 | / | Unkown | |
| HY-E70609 | PIK3CG Recombinant Human Active Lipid Kinase | / | Unkown | |
| HY-E70631 | PIP5K1A Recombinant Human Active Lipid Kinase | / | Unkown | |
| HY-E70789 | BCR-RET Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-E70855 | PKCζ Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-G0007S | Omeprazole sulfone-d3 | Control | / | Unkown |
| HY-G0007S1 | Omeprazole sulfone-13C,d3 | Control | / | Unkown |
| HY-N0361S | Dihydrocapsaicin-d3 | / | Unkown | |
| HY-N0392R | Polygalasaponin F (Standard) | Inhibitor | / | Unkown |
| HY-N0448A | (±)-10-Gingerol | / | Unkown | |
| HY-N0448R | 10-Gingerol (Standard) | / | Unkown | |
| HY-N0479S | Licarin B-d4 | / | Unkown | |
| HY-N0565AG | Doxycycline (hydrochloride) (GMP) | / | Unkown | |
| HY-N0608S | Myrislignan-13C,d2 | / | Unkown | |
| HY-N0660R | Jujuboside B (Standard) | / | Unkown | |
| HY-N0717S2 | L-Valine-13C5,15N,d8 | 99.3% | Unkown | |
| HY-N0717S3 | L-Valine-13C5,15N,d2 | / | Unkown | |
| HY-N0717S5 | L-Valine-2-13C | / | Unkown | |
| HY-N0717S8 | L-Valine-d1 | 98.0% | Unkown | |
| HY-N0717S9 | L-Valine-15N,d8 | / | Unkown | |
| HY-N0776R | Isorhamnetin (Standard) | Inhibitor | / | Unkown |
| HY-N10106 | Dihydromyristicin | Inhibitor | / | Unkown |
| HY-N10342 | Cajanol | / | Unkown | |
| HY-N10802 | 6-O-Isobutyrylbritannilactone | Inhibitor | 98.34% | Unkown |
| HY-N12489 | Ishophloroglucin A | / | Unkown | |
| HY-N1255A | Scoulerine hydrochloride | / | Unkown | |
| HY-N12959 | 5,4'-Dihydroxy-6,8-dimethoxy-7-O-rhamnosyl flavone | Inhibitor | / | Unkown |
| HY-N13063 | Anticancer agent 235 | / | Unkown | |
| HY-N1338 | Royleanone | Inhibitor | / | Unkown |
| HY-N15902 | BODIPY 505/515 TMR PI(3,4,5)P3 ammonium | / | Unkown | |
| HY-N15977 | 18:1-6:0 Biotin PI(3,5)P2 ammonium) | / | Unkown | |
| HY-N16118 | Asperosaponin V | Modulator | / | Unkown |
| HY-N18161 | Isopsoralidin | Inhibitor | / | Unkown |
| HY-N19103 | 3-(2-Hydroxypropyl)-8-hydroxy-3,4-dihydroisocoumarin | / | Unkown | |
| HY-N2026AR | Propylparaben sodium (Standard) | / | Unkown | |
| HY-N2026S | Propylparaben-d7 | / | Unkown | |
| HY-N3000A | 6-Methoxydihydrosanguinarine hydrochloride | / | Unkown | |
| HY-N8931 | Monomethyl lithospermate | Activator | / | Unkown |
| HY-N9602 | 6,7,4'-Trihydroxyflavanone | / | Unkown | |
| HY-N9980 | Antcin K | Inhibitor | / | Unkown |
| HY-P0175A | 740 Y-P TFA | / | Unkown | |
| HY-P10093 | Penetratin-PI3Kγ(126-150) | Inhibitor | / | Unkown |
| HY-P10320 | T3 Peptide | Activator | / | Unkown |
| HY-P10833 | C-VGB3 | / | Unkown | |
| HY-P10981 | ErbB2 peptide | Ligand | / | Unkown |
| HY-P10992 | YVPGP | / | Unkown | |
| HY-P11130 | LQEQ-19 (mouse, rat) | Activator | / | Unkown |
| HY-P11313 | Catestatin (rat) | / | Unkown | |
| HY-P4790 | Acetyl-Exenatide | Inhibitor | / | Unkown |
| HY-RS10463 | PI3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W009141S | 1-Monopalmitin-d31 | / | Unkown | |
| HY-W010201S1 | Citronellol-d3 | / | Unkown | |
| HY-W711035 | Picolinafen | / | Unkown | |
| HY-W714183 | Dinitramine | / | Unkown | |
| HY-W783478 | Calebin A | Inhibitor | 98.0% | Unkown |
| HY-W934539 | Lenalidomide-amide-C8-Br | / | Unkown | |
| HY-W940885 | Pomalidomide-NH-C13-OH | / | Unkown | |
| HY-100603B | (R)-GSK-F1 | Inhibitor | / | Unkown |
| HY-10202B | Tandutinib sulfate | / | Unkown | |
| HY-10549 | PI3Kγ inhibitor 1 | Inhibitor | / | Unkown |
| HY-105854A | Pipoxolan | / | Unkown | |
| HY-107207R | Kaempferol 3-neohesperidoside (Standard) | / | Unkown | |
| HY-107216A | (3aS,4R,9bR)-G-1 | / | Unkown | |
| HY-110038 | FTI-277 TFA | / | Unkown | |
| HY-113308AS1 | Taurolithocholic Acid-d5 sodium salt | / | Unkown | |
| HY-113402AR | Gamma-glutamylcysteine TFA (Standard) | / | Unkown | |
| HY-113402B | Gamma-glutamylcysteine ammonium | / | Unkown | |
| HY-114457 | Phosphatidylinositol 4,5-bisphosphate | Substrate | / | Unkown |
| HY-116191 | WJD008 | Inhibitor | / | Unkown |
| HY-116563 | PI3Kα-IN-24 | Inhibitor | / | Unkown |
| HY-117885 | PF-5177624 | Inhibitor | / | Unkown |
| HY-117923 | PF-06465603 | Inhibitor | / | Unkown |
| HY-118236 | (S)-AZD 6482 | / | Unkown | |
| HY-118374 | AM-9635 | Inhibitor | / | Unkown |
| HY-120471 | AM-0687 | Inhibitor | / | Unkown |
| HY-121672 | PI3K-IN-7 | / | Unkown | |
| HY-121684 | Ramentaceone | / | Unkown | |
| HY-123790 | AS2541019 | Inhibitor | / | Unkown |
| HY-12491 | PIK-C98 | / | Unkown | |
| HY-12517 | GNE-293 | Inhibitor | / | Unkown |
| HY-128393S1 | Trilinolein-13C54 | / | Unkown | |
| HY-136700 | SB-699551 free base | / | Unkown | |
| HY-148965A | PtdIns-(3)-P1 (1,2-dipalmitoyl) ammonium | / | Unkown | |
| HY-150309 | PI3K-IN-54 | Inhibitor | / | Unkown |
| HY-15288 | PI3kδ inhibitor 1 | Inhibitor | / | Unkown |
| HY-155211 | mTOR inhibitor-13 | Inhibitor | / | Unkown |
| HY-15643 | LY 303511 | / | Unkown | |
| HY-156484 | SPR519 | Inhibitor | / | Unkown |
| HY-157287 | (S)-Phe-A110/B319 | / | Unkown | |
| HY-157288 | (R)-Phe-A110/B319 | / | Unkown | |
| HY-157649 | 18:0-20:4 PI (3,5) P2 triammonium | / | Unkown | |
| HY-157685 | 06:0 PI(3,5)P2 ammonium | / | Unkown | |
| HY-157706 | PI(3,4)P2 (18:1) ammonium salt | Activator | / | Unkown |
| HY-157713 | diC8PI(3,5)P2 triammonium | / | Unkown | |
| HY-160458 | PI3Kα-IN-17 | Inhibitor | / | Unkown |
| HY-16122 | CAL-130 Racemate | Inhibitor | / | Unkown |
| HY-16122A | CAL-130 | Inhibitor | / | Unkown |
| HY-162023 | mTOR inhibitor-10 | Inhibitor | / | Unkown |
| HY-162024 | mTOR inhibitor-16 | Inhibitor | / | Unkown |
| HY-162025 | mTOR inhibitor-17 | Inhibitor | / | Unkown |
| HY-164384 | DFX117 | / | Unkown | |
| HY-164548 | WK88-1 | / | Unkown | |
| HY-164662 | mTOR inhibitor-24 | Inhibitor | / | Unkown |
| HY-167952 | mTOR inhibitor-25 | / | Unkown | |
| HY-172742 | Dioctanoyl PI(3,4)P2 sodium | / | Unkown | |
| HY-174645 | Human IL10RA mRNA | / | Unkown | |
| HY-175083 | PtdIns-(4,5)-P2-biotin trisodium | Substrate | / | Unkown |
| HY-175086 | PtdIns-(3,4,5)-P3-fluorescein triethylammonium | / | Unkown | |
| HY-175089 | PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) sodium | / | Unkown | |
| HY-175407 | 18:0-20:4 PI(3,4,5)P3 sodium | / | Unkown | |
| HY-175862 | ALR2-IN-9 | / | Unkown | |
| HY-176832 | PtdIns-(3,4)-P2 (1,2-dipalmitoyl) sodium | / | Unkown | |
| HY-178445 | PI3Kδ-IN-27 | Inhibitor | / | Unkown |
| HY-178775 | PI4K-IN-3 | Inhibitor | / | Unkown |
| HY-179554 | PtdIns-(4,5)-P2-fluorescein triethylammonium | / | Unkown | |
| HY-181963 | ZINC-1000507824 | / | Unkown | |
| HY-185185 | S58 aptamer | / | Unkown | |
| HY-185456 | PI3K/mTOR-IN-21 | Inhibitor | / | Unkown |
| HY-185457 | BrAC-GGFG-Aminal-PI3K/mTOR-IN-21 | Inhibitor | / | Unkown |
| HY-90003S | Tianeptine-d12 | / | Unkown | |
| HY-B0965S | Thioridazine 2-Sulfone-d3 | / | Unkown | |
| HY-B1234S | Octinoxate-13C,d3 | / | Unkown | |
| HY-N0143R | Phlorizin (Standard) | / | Unkown | |
| HY-N0493R | Pectolinarigenin (Standard) | / | Unkown | |
| HY-N0699R | Daphnoretin (Standard) | / | Unkown | |
| HY-N0717S7 | L-Valine-1-13C,15N | / | Unkown | |
| HY-N0819R | Raddeanin A (Standard) | Inducer | / | Unkown |
| HY-N10133 | Licoflavanone | / | Unkown | |
| HY-N12531 | Molephantin | / | Unkown | |
| HY-N13164 | Polygalacin D3 | / | Unkown | |
| HY-N1431A | Tabersonine hydrochloride | 98.55% | Unkown | |
| HY-N2037AS1 | Higenamine-d4-1 hydrochloride | / | Unkown | |
| HY-N4189 | Isocucurbitacin B | 98.98% | Unkown | |
| HY-N6926 | 1,3,5-Tricaffeoylquinic acid | / | Unkown | |
| HY-N8380 | (-)-Latifolin | / | Unkown | |
| HY-N9164 | Hecubine | / | Unkown | |
| HY-P10393 | ERα17p | Inducer | / | Unkown |
| HY-W010201S | Citronellol-d6 | Activator | / | Unkown |
| HY-W636234 | GSK2636771 methyl | Inhibitor | / | Unkown |
| HY-W714214 | Ethalfluralin | / | Unkown | |
| HY-W937057 | (S,R,S)-AHPC-Me-10-bromodecanoic acid | / | Unkown | |
| HY-Y1177R | Diphenyl disulfide (Standard) | / | Unkown | |
| HY-122593 | PI3Kδ-IN-5 | Inhibitor | 99.62% | Unkown |
| HY-18310 | NIBR-17 | Inhibitor | 98.00% | Unkown |
Bioactive MoleculesInhibitory Antibodies
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991220 | AL002 | Agonist | 98.01% | Unkown |
| HY-P990248 | Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) | Inhibitor | / | Unkown |
| HY-P991234 | COVA208 | / | Unkown | |
| HY-P992200 | Anti-CD146 Antibody (AA98) | / | Unkown | |
| HY-P992401 | M802 | / | Unkown |